US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Latest News about Meded

Recent news which mentions Meded

2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
Tickers CME
Tags Meded HFSA2025 Medical
From PRLog
2025 HFM Symposium - Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
Tickers CME
Tags Medical Heartfailure Cardiomyopathy
From PRLog
2024 NCS CME Symposium - Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage
Tickers CME NCS
Tags United States Medical Ncs
From PRLog
2024 HFSA CME Symposium - From Evidence to Practice: Treating Iron Deficiency with Intravenous Iron in Heart Failure
Tickers CME
Tags Meded Hazlet Event
From PRLog
2024 HFSA CME Symposium - Mastering the Dynamics of Worsening HFrEF: An In-Depth Approach to Effective Management
Tickers CME
Tags Hazlet Meded Cme
From PRLog
2024 HFMC CME Symposium - Managing Worsening Heart Failure with Reduced Ejection Fraction: Strategies for Successful Outcomes
Tickers CME
Tags Cardiology Heartfailure United States
From PRLog
2024 AMCP CME Symposium - Exploring the Impact of Intravenous Iron for Iron Deficiency in Heart Failure
Tickers CME
Tags United States Pharmacy Medical
From PRLog
2023 AHA CME Symposium - Translating Clinical Trials to Clinical Practice: Improving HF Outcomes with Intravenous Iron
Tickers CME HF IRON
Tags New Jersey hf Aha
From PRLog